Search Results - "Spraul, Anne"
-
1
Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4‐phenylbutyrate
Published in Hepatology (Baltimore, Md.) (01-08-2015)“…Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a result of mutations in ABCB11 encoding bile salt export pump (BSEP), the canalicular bile…”
Get full text
Journal Article -
2
ATP8B1 and ABCB11 analysis in 62 children with normal gamma‐glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history
Published in Hepatology (Baltimore, Md.) (01-05-2010)“…Progressive familial intrahepatic cholestasis (PFIC) types 1 and 2 are characterized by normal serum gamma‐glutamyl transferase (GGT) activity and are due to…”
Get full text
Journal Article -
3
A functional classification of ABCB4 variations causing progressive familial intrahepatic cholestasis type 3
Published in Hepatology (Baltimore, Md.) (01-05-2016)“…Progressive familial intrahepatic cholestasis type 3 is caused by biallelic variations of ABCB4, most often (≥70%) missense. In this study, we examined the…”
Get full text
Journal Article -
4
MYO5B mutations cause cholestasis with normal serum gamma‐glutamyl transferase activity in children without microvillous inclusion disease
Published in Hepatology (Baltimore, Md.) (01-01-2017)“…Some patients with microvillus inclusion disease due to myosin 5B (MYO5B) mutations may develop cholestasis characterized by a progressive familial…”
Get full text
Journal Article -
5
A Novel CFC1 Mutation in a Family With Heterotaxy and Biliary Atresia Splenic Malformation Syndromes
Published in Journal of pediatric gastroenterology and nutrition (01-01-2020)Get full text
Journal Article -
6
Progressive familial intrahepatic cholestasis
Published in Orphanet journal of rare diseases (08-01-2009)“…Progressive familial intrahepatic cholestasis (PFIC) refers to heterogeneous group of autosomal recessive disorders of childhood that disrupt bile formation…”
Get full text
Journal Article -
7
Pharmacological Premature Termination Codon Readthrough of ABCB11 in Bile Salt Export Pump Deficiency: An In Vitro Study
Published in Hepatology (Baltimore, Md.) (01-04-2021)“…Background and Aims Progressive familial intrahepatic cholestasis type 2 (PFIC2) is a severe hepatocellular cholestasis due to biallelic mutations in ABCB11…”
Get full text
Journal Article -
8
Failure of cholic acid therapy in a child with a bile acid synthesis defect and harboring plectin mutations
Published in Journal of pediatric gastroenterology and nutrition (01-05-2024)Get full text
Journal Article -
9
Functional rescue of an ABCB11 mutant by ivacaftor: A new targeted pharmacotherapy approach in bile salt export pump deficiency
Published in Liver international (01-08-2020)“…Background & Aim The canalicular bile salt export pump (BSEP/ABCB11) of hepatocytes is the main adenosine triphosphate (ATP)‐binding cassette (ABC) transporter…”
Get full text
Journal Article -
10
The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
Published in Hepatology (Baltimore, Md.) (01-10-2013)“…Many regulatory pathways are involved in liver regeneration after partial hepatectomy (PH) to initiate growth, protect liver cells, and sustain functions of…”
Get full text
Journal Article -
11
MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease
Published in Hepatology (Baltimore, Md.) (01-07-2014)“…Microvillous inclusion disease (MVID) is a congenital disorder of the enterocyte related to mutations in the MYO5B gene, leading to intractable diarrhea often…”
Get full text
Journal Article -
12
CFC1 Gene Involvement in Biliary Atresia With Polysplenia Syndrome
Published in Journal of pediatric gastroenterology and nutrition (01-01-2008)“…ABSTRACT The present report describes CFC1 gene analysis in 10 patients with polysplenia syndrome. The heterozygous transition c.433G>A (Ala145Thr) located in…”
Get full text
Journal Article -
13
Clinical utility gene card for: progressive familial intrahepatic cholestasis type 2
Published in European journal of human genetics : EJHG (01-04-2014)Get full text
Journal Article -
14
Oral Cholic Acid for Hereditary Defects of Primary Bile Acid Synthesis: A Safe and Effective Long-term Therapy
Published in Gastroenterology (New York, N.Y. 1943) (01-10-2009)“…Background & Aims Oral bile acid replacement has been shown to be an effective therapy in primary bile acid synthesis defects, but to date there have been no…”
Get full text
Journal Article -
15
TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function
Published in Gut (01-01-2020)“…We explored the hypothesis that TGR5, the bile acid (BA) G-protein-coupled receptor highly expressed in biliary epithelial cells, protects the liver against BA…”
Get more information
Journal Article -
16
Initial presentation, management and follow-up data of 33 treated patients with hereditary tyrosinemia type 1 in the absence of newborn screening
Published in Molecular genetics and metabolism reports (01-12-2022)“…Hereditary tyrosinemia type 1 (HT1) is a rare autosomal recessive disorder of phenylalanine and tyrosine catabolism due to a deficiency of fumarylacetoacetate…”
Get full text
Journal Article -
17
Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis
Published in Diagnostics (Basel) (07-05-2022)“…Cholestasis is a frequent and severe condition during childhood. Genetic cholestatic diseases represent up to 25% of pediatric cholestasis. Molecular analysis…”
Get full text
Journal Article -
18
Heterozygous FIC1 Deficiency: A New Genetic Predisposition to Transient Neonatal Cholestasis
Published in Journal of pediatric gastroenterology and nutrition (01-04-2010)Get full text
Journal Article -
19
4 -3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid
Published in Orphanet journal of rare diseases (07-12-2023)“…Oral cholic acid therapy is an effective therapy in children with primary bile acid synthesis deficiencies. Most reported patients with this treatment have…”
Get full text
Journal Article -
20
Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease
Published in Liver international (01-10-2005)“…: Aims: Steatosis may increase oxidative stress, which is counteracted by cellular enzymatic (cytosolic and mitochondrial superoxide dismutases (Cu/Zn‐SOD and…”
Get full text
Journal Article